Global Cell Therapy Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Cell Therapy Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Page: 126

Published Date: 06 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Cell Therapy Regenerative Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

This report studies the global Cell Therapy Regenerative Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell Therapy Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy Regenerative Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell Therapy Regenerative Medicine total production and demand, 2018-2029, (K Units)
Global Cell Therapy Regenerative Medicine total production value, 2018-2029, (USD Million)
Global Cell Therapy Regenerative Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cell Therapy Regenerative Medicine domestic production, consumption, key domestic manufacturers and share
Global Cell Therapy Regenerative Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Cell Therapy Regenerative Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy Regenerative Medicine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell Therapy Regenerative Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell Therapy Regenerative Medicine Market, Segmentation by Type
NK Cell Therapy
CAR-T Cell Therapy
Others

Global Cell Therapy Regenerative Medicine Market, Segmentation by Application
Hospital
Medical Research Center
Others

Companies Profiled:
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Key Questions Answered
1. How big is the global Cell Therapy Regenerative Medicine market?
2. What is the demand of the global Cell Therapy Regenerative Medicine market?
3. What is the year over year growth of the global Cell Therapy Regenerative Medicine market?
4. What is the production and production value of the global Cell Therapy Regenerative Medicine market?
5. Who are the key producers in the global Cell Therapy Regenerative Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Cell Therapy Regenerative Medicine Introduction
1.2 World Cell Therapy Regenerative Medicine Supply & Forecast
1.2.1 World Cell Therapy Regenerative Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Cell Therapy Regenerative Medicine Production (2018-2029)
1.2.3 World Cell Therapy Regenerative Medicine Pricing Trends (2018-2029)
1.3 World Cell Therapy Regenerative Medicine Production by Region (Based on Production Site)
1.3.1 World Cell Therapy Regenerative Medicine Production Value by Region (2018-2029)
1.3.2 World Cell Therapy Regenerative Medicine Production by Region (2018-2029)
1.3.3 World Cell Therapy Regenerative Medicine Average Price by Region (2018-2029)
1.3.4 North America Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.5 Europe Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.6 China Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.7 Japan Cell Therapy Regenerative Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Cell Therapy Regenerative Medicine Demand (2018-2029)
2.2 World Cell Therapy Regenerative Medicine Consumption by Region
2.2.1 World Cell Therapy Regenerative Medicine Consumption by Region (2018-2023)
2.2.2 World Cell Therapy Regenerative Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.4 China Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.5 Europe Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.6 Japan Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.7 South Korea Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.8 ASEAN Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.9 India Cell Therapy Regenerative Medicine Consumption (2018-2029)

3 World Cell Therapy Regenerative Medicine Manufacturers Competitive Analysis
3.1 World Cell Therapy Regenerative Medicine Production Value by Manufacturer (2018-2023)
3.2 World Cell Therapy Regenerative Medicine Production by Manufacturer (2018-2023)
3.3 World Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Cell Therapy Regenerative Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cell Therapy Regenerative Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cell Therapy Regenerative Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Cell Therapy Regenerative Medicine in 2022
3.6 Cell Therapy Regenerative Medicine Market: Overall Company Footprint Analysis
3.6.1 Cell Therapy Regenerative Medicine Market: Region Footprint
3.6.2 Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
3.6.3 Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Cell Therapy Regenerative Medicine Production Value Comparison
4.1.1 United States VS China: Cell Therapy Regenerative Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cell Therapy Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cell Therapy Regenerative Medicine Production Comparison
4.2.1 United States VS China: Cell Therapy Regenerative Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cell Therapy Regenerative Medicine Consumption Comparison
4.3.1 United States VS China: Cell Therapy Regenerative Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cell Therapy Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cell Therapy Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)
4.5 China Based Cell Therapy Regenerative Medicine Manufacturers and Market Share
4.5.1 China Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)
4.6 Rest of World Based Cell Therapy Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)

5 Market Analysis by Type
5.1 World Cell Therapy Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 NK Cell Therapy
5.2.2 CAR-T Cell Therapy
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cell Therapy Regenerative Medicine Production by Type (2018-2029)
5.3.2 World Cell Therapy Regenerative Medicine Production Value by Type (2018-2029)
5.3.3 World Cell Therapy Regenerative Medicine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Cell Therapy Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Medical Research Center
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cell Therapy Regenerative Medicine Production by Application (2018-2029)
6.3.2 World Cell Therapy Regenerative Medicine Production Value by Application (2018-2029)
6.3.3 World Cell Therapy Regenerative Medicine Average Price by Application (2018-2029)

7 Company Profiles
7.1 DePuy Synthes
7.1.1 DePuy Synthes Details
7.1.2 DePuy Synthes Major Business
7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
7.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 DePuy Synthes Recent Developments/Updates
7.1.6 DePuy Synthes Competitive Strengths & Weaknesses
7.2 Medtronic
7.2.1 Medtronic Details
7.2.2 Medtronic Major Business
7.2.3 Medtronic Cell Therapy Regenerative Medicine Product and Services
7.2.4 Medtronic Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Medtronic Recent Developments/Updates
7.2.6 Medtronic Competitive Strengths & Weaknesses
7.3 ZimmerBiomet
7.3.1 ZimmerBiomet Details
7.3.2 ZimmerBiomet Major Business
7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
7.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 ZimmerBiomet Recent Developments/Updates
7.3.6 ZimmerBiomet Competitive Strengths & Weaknesses
7.4 Stryker
7.4.1 Stryker Details
7.4.2 Stryker Major Business
7.4.3 Stryker Cell Therapy Regenerative Medicine Product and Services
7.4.4 Stryker Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Stryker Recent Developments/Updates
7.4.6 Stryker Competitive Strengths & Weaknesses
7.5 Acelity
7.5.1 Acelity Details
7.5.2 Acelity Major Business
7.5.3 Acelity Cell Therapy Regenerative Medicine Product and Services
7.5.4 Acelity Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Acelity Recent Developments/Updates
7.5.6 Acelity Competitive Strengths & Weaknesses
7.6 MiMedx Group
7.6.1 MiMedx Group Details
7.6.2 MiMedx Group Major Business
7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Product and Services
7.6.4 MiMedx Group Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 MiMedx Group Recent Developments/Updates
7.6.6 MiMedx Group Competitive Strengths & Weaknesses
7.7 Organogenesis
7.7.1 Organogenesis Details
7.7.2 Organogenesis Major Business
7.7.3 Organogenesis Cell Therapy Regenerative Medicine Product and Services
7.7.4 Organogenesis Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Organogenesis Recent Developments/Updates
7.7.6 Organogenesis Competitive Strengths & Weaknesses
7.8 UniQure
7.8.1 UniQure Details
7.8.2 UniQure Major Business
7.8.3 UniQure Cell Therapy Regenerative Medicine Product and Services
7.8.4 UniQure Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UniQure Recent Developments/Updates
7.8.6 UniQure Competitive Strengths & Weaknesses
7.9 Cellular Dynamics International
7.9.1 Cellular Dynamics International Details
7.9.2 Cellular Dynamics International Major Business
7.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
7.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Cellular Dynamics International Recent Developments/Updates
7.9.6 Cellular Dynamics International Competitive Strengths & Weaknesses
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Details
7.10.2 Osiris Therapeutics Major Business
7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
7.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Osiris Therapeutics Recent Developments/Updates
7.10.6 Osiris Therapeutics Competitive Strengths & Weaknesses
7.11 Vcanbio
7.11.1 Vcanbio Details
7.11.2 Vcanbio Major Business
7.11.3 Vcanbio Cell Therapy Regenerative Medicine Product and Services
7.11.4 Vcanbio Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Vcanbio Recent Developments/Updates
7.11.6 Vcanbio Competitive Strengths & Weaknesses
7.12 Gamida Cell
7.12.1 Gamida Cell Details
7.12.2 Gamida Cell Major Business
7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Product and Services
7.12.4 Gamida Cell Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Gamida Cell Recent Developments/Updates
7.12.6 Gamida Cell Competitive Strengths & Weaknesses
7.13 Golden Meditech
7.13.1 Golden Meditech Details
7.13.2 Golden Meditech Major Business
7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Product and Services
7.13.4 Golden Meditech Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Golden Meditech Recent Developments/Updates
7.13.6 Golden Meditech Competitive Strengths & Weaknesses
7.14 Cytori
7.14.1 Cytori Details
7.14.2 Cytori Major Business
7.14.3 Cytori Cell Therapy Regenerative Medicine Product and Services
7.14.4 Cytori Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Cytori Recent Developments/Updates
7.14.6 Cytori Competitive Strengths & Weaknesses
7.15 Celgene
7.15.1 Celgene Details
7.15.2 Celgene Major Business
7.15.3 Celgene Cell Therapy Regenerative Medicine Product and Services
7.15.4 Celgene Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Celgene Recent Developments/Updates
7.15.6 Celgene Competitive Strengths & Weaknesses
7.16 Vericel Corporation
7.16.1 Vericel Corporation Details
7.16.2 Vericel Corporation Major Business
7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
7.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Vericel Corporation Recent Developments/Updates
7.16.6 Vericel Corporation Competitive Strengths & Weaknesses
7.17 Guanhao Biotech
7.17.1 Guanhao Biotech Details
7.17.2 Guanhao Biotech Major Business
7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
7.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Guanhao Biotech Recent Developments/Updates
7.17.6 Guanhao Biotech Competitive Strengths & Weaknesses
7.18 Mesoblast
7.18.1 Mesoblast Details
7.18.2 Mesoblast Major Business
7.18.3 Mesoblast Cell Therapy Regenerative Medicine Product and Services
7.18.4 Mesoblast Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Mesoblast Recent Developments/Updates
7.18.6 Mesoblast Competitive Strengths & Weaknesses
7.19 Stemcell Technologies
7.19.1 Stemcell Technologies Details
7.19.2 Stemcell Technologies Major Business
7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
7.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Stemcell Technologies Recent Developments/Updates
7.19.6 Stemcell Technologies Competitive Strengths & Weaknesses
7.20 Bellicum Pharmaceuticals
7.20.1 Bellicum Pharmaceuticals Details
7.20.2 Bellicum Pharmaceuticals Major Business
7.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
7.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Bellicum Pharmaceuticals Recent Developments/Updates
7.20.6 Bellicum Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Cell Therapy Regenerative Medicine Industry Chain
8.2 Cell Therapy Regenerative Medicine Upstream Analysis
8.2.1 Cell Therapy Regenerative Medicine Core Raw Materials
8.2.2 Main Manufacturers of Cell Therapy Regenerative Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cell Therapy Regenerative Medicine Production Mode
8.6 Cell Therapy Regenerative Medicine Procurement Model
8.7 Cell Therapy Regenerative Medicine Industry Sales Model and Sales Channels
8.7.1 Cell Therapy Regenerative Medicine Sales Model
8.7.2 Cell Therapy Regenerative Medicine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Cell Therapy Regenerative Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cell Therapy Regenerative Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cell Therapy Regenerative Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Cell Therapy Regenerative Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Cell Therapy Regenerative Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Cell Therapy Regenerative Medicine Production Market Share by Region (2018-2023)
Table 9. World Cell Therapy Regenerative Medicine Production Market Share by Region (2024-2029)
Table 10. World Cell Therapy Regenerative Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cell Therapy Regenerative Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cell Therapy Regenerative Medicine Major Market Trends
Table 13. World Cell Therapy Regenerative Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cell Therapy Regenerative Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Cell Therapy Regenerative Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cell Therapy Regenerative Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cell Therapy Regenerative Medicine Producers in 2022
Table 18. World Cell Therapy Regenerative Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cell Therapy Regenerative Medicine Producers in 2022
Table 20. World Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cell Therapy Regenerative Medicine Company Evaluation Quadrant
Table 22. World Cell Therapy Regenerative Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cell Therapy Regenerative Medicine Production Site of Key Manufacturer
Table 24. Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
Table 25. Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
Table 26. Cell Therapy Regenerative Medicine Competitive Factors
Table 27. Cell Therapy Regenerative Medicine New Entrant and Capacity Expansion Plans
Table 28. Cell Therapy Regenerative Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Cell Therapy Regenerative Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cell Therapy Regenerative Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cell Therapy Regenerative Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 37. China Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 47. World Cell Therapy Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cell Therapy Regenerative Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Cell Therapy Regenerative Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Cell Therapy Regenerative Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cell Therapy Regenerative Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cell Therapy Regenerative Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cell Therapy Regenerative Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cell Therapy Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cell Therapy Regenerative Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Cell Therapy Regenerative Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Cell Therapy Regenerative Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cell Therapy Regenerative Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cell Therapy Regenerative Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cell Therapy Regenerative Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. DePuy Synthes Basic Information, Manufacturing Base and Competitors
Table 62. DePuy Synthes Major Business
Table 63. DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
Table 64. DePuy Synthes Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. DePuy Synthes Recent Developments/Updates
Table 66. DePuy Synthes Competitive Strengths & Weaknesses
Table 67. Medtronic Basic Information, Manufacturing Base and Competitors
Table 68. Medtronic Major Business
Table 69. Medtronic Cell Therapy Regenerative Medicine Product and Services
Table 70. Medtronic Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Medtronic Recent Developments/Updates
Table 72. Medtronic Competitive Strengths & Weaknesses
Table 73. ZimmerBiomet Basic Information, Manufacturing Base and Competitors
Table 74. ZimmerBiomet Major Business
Table 75. ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
Table 76. ZimmerBiomet Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. ZimmerBiomet Recent Developments/Updates
Table 78. ZimmerBiomet Competitive Strengths & Weaknesses
Table 79. Stryker Basic Information, Manufacturing Base and Competitors
Table 80. Stryker Major Business
Table 81. Stryker Cell Therapy Regenerative Medicine Product and Services
Table 82. Stryker Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Stryker Recent Developments/Updates
Table 84. Stryker Competitive Strengths & Weaknesses
Table 85. Acelity Basic Information, Manufacturing Base and Competitors
Table 86. Acelity Major Business
Table 87. Acelity Cell Therapy Regenerative Medicine Product and Services
Table 88. Acelity Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Acelity Recent Developments/Updates
Table 90. Acelity Competitive Strengths & Weaknesses
Table 91. MiMedx Group Basic Information, Manufacturing Base and Competitors
Table 92. MiMedx Group Major Business
Table 93. MiMedx Group Cell Therapy Regenerative Medicine Product and Services
Table 94. MiMedx Group Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. MiMedx Group Recent Developments/Updates
Table 96. MiMedx Group Competitive Strengths & Weaknesses
Table 97. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 98. Organogenesis Major Business
Table 99. Organogenesis Cell Therapy Regenerative Medicine Product and Services
Table 100. Organogenesis Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Organogenesis Recent Developments/Updates
Table 102. Organogenesis Competitive Strengths & Weaknesses
Table 103. UniQure Basic Information, Manufacturing Base and Competitors
Table 104. UniQure Major Business
Table 105. UniQure Cell Therapy Regenerative Medicine Product and Services
Table 106. UniQure Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UniQure Recent Developments/Updates
Table 108. UniQure Competitive Strengths & Weaknesses
Table 109. Cellular Dynamics International Basic Information, Manufacturing Base and Competitors
Table 110. Cellular Dynamics International Major Business
Table 111. Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
Table 112. Cellular Dynamics International Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Cellular Dynamics International Recent Developments/Updates
Table 114. Cellular Dynamics International Competitive Strengths & Weaknesses
Table 115. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Osiris Therapeutics Major Business
Table 117. Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
Table 118. Osiris Therapeutics Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Osiris Therapeutics Recent Developments/Updates
Table 120. Osiris Therapeutics Competitive Strengths & Weaknesses
Table 121. Vcanbio Basic Information, Manufacturing Base and Competitors
Table 122. Vcanbio Major Business
Table 123. Vcanbio Cell Therapy Regenerative Medicine Product and Services
Table 124. Vcanbio Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Vcanbio Recent Developments/Updates
Table 126. Vcanbio Competitive Strengths & Weaknesses
Table 127. Gamida Cell Basic Information, Manufacturing Base and Competitors
Table 128. Gamida Cell Major Business
Table 129. Gamida Cell Cell Therapy Regenerative Medicine Product and Services
Table 130. Gamida Cell Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Gamida Cell Recent Developments/Updates
Table 132. Gamida Cell Competitive Strengths & Weaknesses
Table 133. Golden Meditech Basic Information, Manufacturing Base and Competitors
Table 134. Golden Meditech Major Business
Table 135. Golden Meditech Cell Therapy Regenerative Medicine Product and Services
Table 136. Golden Meditech Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Golden Meditech Recent Developments/Updates
Table 138. Golden Meditech Competitive Strengths & Weaknesses
Table 139. Cytori Basic Information, Manufacturing Base and Competitors
Table 140. Cytori Major Business
Table 141. Cytori Cell Therapy Regenerative Medicine Product and Services
Table 142. Cytori Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Cytori Recent Developments/Updates
Table 144. Cytori Competitive Strengths & Weaknesses
Table 145. Celgene Basic Information, Manufacturing Base and Competitors
Table 146. Celgene Major Business
Table 147. Celgene Cell Therapy Regenerative Medicine Product and Services
Table 148. Celgene Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Celgene Recent Developments/Updates
Table 150. Celgene Competitive Strengths & Weaknesses
Table 151. Vericel Corporation Basic Information, Manufacturing Base and Competitors
Table 152. Vericel Corporation Major Business
Table 153. Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
Table 154. Vericel Corporation Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Vericel Corporation Recent Developments/Updates
Table 156. Vericel Corporation Competitive Strengths & Weaknesses
Table 157. Guanhao Biotech Basic Information, Manufacturing Base and Competitors
Table 158. Guanhao Biotech Major Business
Table 159. Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
Table 160. Guanhao Biotech Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Guanhao Biotech Recent Developments/Updates
Table 162. Guanhao Biotech Competitive Strengths & Weaknesses
Table 163. Mesoblast Basic Information, Manufacturing Base and Competitors
Table 164. Mesoblast Major Business
Table 165. Mesoblast Cell Therapy Regenerative Medicine Product and Services
Table 166. Mesoblast Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Mesoblast Recent Developments/Updates
Table 168. Mesoblast Competitive Strengths & Weaknesses
Table 169. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 170. Stemcell Technologies Major Business
Table 171. Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
Table 172. Stemcell Technologies Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Stemcell Technologies Recent Developments/Updates
Table 174. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 175. Bellicum Pharmaceuticals Major Business
Table 176. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
Table 177. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Cell Therapy Regenerative Medicine Upstream (Raw Materials)
Table 179. Cell Therapy Regenerative Medicine Typical Customers
Table 180. Cell Therapy Regenerative Medicine Typical Distributors
List of Figure
Figure 1. Cell Therapy Regenerative Medicine Picture
Figure 2. World Cell Therapy Regenerative Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy Regenerative Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 5. World Cell Therapy Regenerative Medicine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Cell Therapy Regenerative Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 10. China Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 12. Cell Therapy Regenerative Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Cell Therapy Regenerative Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cell Therapy Regenerative Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cell Therapy Regenerative Medicine Markets in 2022
Figure 26. United States VS China: Cell Therapy Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cell Therapy Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 32. World Cell Therapy Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cell Therapy Regenerative Medicine Production Value Market Share by Type in 2022
Figure 34. NK Cell Therapy
Figure 35. CAR-T Cell Therapy
Figure 36. Others
Figure 37. World Cell Therapy Regenerative Medicine Production Market Share by Type (2018-2029)
Figure 38. World Cell Therapy Regenerative Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Cell Therapy Regenerative Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Cell Therapy Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Cell Therapy Regenerative Medicine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Medical Research Center
Figure 44. Others
Figure 45. World Cell Therapy Regenerative Medicine Production Market Share by Application (2018-2029)
Figure 46. World Cell Therapy Regenerative Medicine Production Value Market Share by Application (2018-2029)
Figure 47. World Cell Therapy Regenerative Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Cell Therapy Regenerative Medicine Industry Chain
Figure 49. Cell Therapy Regenerative Medicine Procurement Model
Figure 50. Cell Therapy Regenerative Medicine Sales Model
Figure 51. Cell Therapy Regenerative Medicine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cell Therapy Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Global Cell Therapy Regenerative Medicine Supply, Demand and Key Producers, 2023-2029

Page: 126

Published Date: 06 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Cell Therapy Regenerative Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

This report studies the global Cell Therapy Regenerative Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell Therapy Regenerative Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy Regenerative Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell Therapy Regenerative Medicine total production and demand, 2018-2029, (K Units)
Global Cell Therapy Regenerative Medicine total production value, 2018-2029, (USD Million)
Global Cell Therapy Regenerative Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cell Therapy Regenerative Medicine domestic production, consumption, key domestic manufacturers and share
Global Cell Therapy Regenerative Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cell Therapy Regenerative Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Cell Therapy Regenerative Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Therapy Regenerative Medicine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell Therapy Regenerative Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell Therapy Regenerative Medicine Market, Segmentation by Type
NK Cell Therapy
CAR-T Cell Therapy
Others

Global Cell Therapy Regenerative Medicine Market, Segmentation by Application
Hospital
Medical Research Center
Others

Companies Profiled:
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Key Questions Answered
1. How big is the global Cell Therapy Regenerative Medicine market?
2. What is the demand of the global Cell Therapy Regenerative Medicine market?
3. What is the year over year growth of the global Cell Therapy Regenerative Medicine market?
4. What is the production and production value of the global Cell Therapy Regenerative Medicine market?
5. Who are the key producers in the global Cell Therapy Regenerative Medicine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Cell Therapy Regenerative Medicine Introduction
1.2 World Cell Therapy Regenerative Medicine Supply & Forecast
1.2.1 World Cell Therapy Regenerative Medicine Production Value (2018 & 2022 & 2029)
1.2.2 World Cell Therapy Regenerative Medicine Production (2018-2029)
1.2.3 World Cell Therapy Regenerative Medicine Pricing Trends (2018-2029)
1.3 World Cell Therapy Regenerative Medicine Production by Region (Based on Production Site)
1.3.1 World Cell Therapy Regenerative Medicine Production Value by Region (2018-2029)
1.3.2 World Cell Therapy Regenerative Medicine Production by Region (2018-2029)
1.3.3 World Cell Therapy Regenerative Medicine Average Price by Region (2018-2029)
1.3.4 North America Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.5 Europe Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.6 China Cell Therapy Regenerative Medicine Production (2018-2029)
1.3.7 Japan Cell Therapy Regenerative Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy Regenerative Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell Therapy Regenerative Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Cell Therapy Regenerative Medicine Demand (2018-2029)
2.2 World Cell Therapy Regenerative Medicine Consumption by Region
2.2.1 World Cell Therapy Regenerative Medicine Consumption by Region (2018-2023)
2.2.2 World Cell Therapy Regenerative Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.4 China Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.5 Europe Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.6 Japan Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.7 South Korea Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.8 ASEAN Cell Therapy Regenerative Medicine Consumption (2018-2029)
2.9 India Cell Therapy Regenerative Medicine Consumption (2018-2029)

3 World Cell Therapy Regenerative Medicine Manufacturers Competitive Analysis
3.1 World Cell Therapy Regenerative Medicine Production Value by Manufacturer (2018-2023)
3.2 World Cell Therapy Regenerative Medicine Production by Manufacturer (2018-2023)
3.3 World Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Cell Therapy Regenerative Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cell Therapy Regenerative Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cell Therapy Regenerative Medicine in 2022
3.5.3 Global Concentration Ratios (CR8) for Cell Therapy Regenerative Medicine in 2022
3.6 Cell Therapy Regenerative Medicine Market: Overall Company Footprint Analysis
3.6.1 Cell Therapy Regenerative Medicine Market: Region Footprint
3.6.2 Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
3.6.3 Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Cell Therapy Regenerative Medicine Production Value Comparison
4.1.1 United States VS China: Cell Therapy Regenerative Medicine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cell Therapy Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cell Therapy Regenerative Medicine Production Comparison
4.2.1 United States VS China: Cell Therapy Regenerative Medicine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell Therapy Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cell Therapy Regenerative Medicine Consumption Comparison
4.3.1 United States VS China: Cell Therapy Regenerative Medicine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cell Therapy Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cell Therapy Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)
4.5 China Based Cell Therapy Regenerative Medicine Manufacturers and Market Share
4.5.1 China Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.5.3 China Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)
4.6 Rest of World Based Cell Therapy Regenerative Medicine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023)

5 Market Analysis by Type
5.1 World Cell Therapy Regenerative Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 NK Cell Therapy
5.2.2 CAR-T Cell Therapy
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cell Therapy Regenerative Medicine Production by Type (2018-2029)
5.3.2 World Cell Therapy Regenerative Medicine Production Value by Type (2018-2029)
5.3.3 World Cell Therapy Regenerative Medicine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Cell Therapy Regenerative Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Medical Research Center
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Cell Therapy Regenerative Medicine Production by Application (2018-2029)
6.3.2 World Cell Therapy Regenerative Medicine Production Value by Application (2018-2029)
6.3.3 World Cell Therapy Regenerative Medicine Average Price by Application (2018-2029)

7 Company Profiles
7.1 DePuy Synthes
7.1.1 DePuy Synthes Details
7.1.2 DePuy Synthes Major Business
7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
7.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 DePuy Synthes Recent Developments/Updates
7.1.6 DePuy Synthes Competitive Strengths & Weaknesses
7.2 Medtronic
7.2.1 Medtronic Details
7.2.2 Medtronic Major Business
7.2.3 Medtronic Cell Therapy Regenerative Medicine Product and Services
7.2.4 Medtronic Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Medtronic Recent Developments/Updates
7.2.6 Medtronic Competitive Strengths & Weaknesses
7.3 ZimmerBiomet
7.3.1 ZimmerBiomet Details
7.3.2 ZimmerBiomet Major Business
7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
7.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 ZimmerBiomet Recent Developments/Updates
7.3.6 ZimmerBiomet Competitive Strengths & Weaknesses
7.4 Stryker
7.4.1 Stryker Details
7.4.2 Stryker Major Business
7.4.3 Stryker Cell Therapy Regenerative Medicine Product and Services
7.4.4 Stryker Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Stryker Recent Developments/Updates
7.4.6 Stryker Competitive Strengths & Weaknesses
7.5 Acelity
7.5.1 Acelity Details
7.5.2 Acelity Major Business
7.5.3 Acelity Cell Therapy Regenerative Medicine Product and Services
7.5.4 Acelity Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Acelity Recent Developments/Updates
7.5.6 Acelity Competitive Strengths & Weaknesses
7.6 MiMedx Group
7.6.1 MiMedx Group Details
7.6.2 MiMedx Group Major Business
7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Product and Services
7.6.4 MiMedx Group Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 MiMedx Group Recent Developments/Updates
7.6.6 MiMedx Group Competitive Strengths & Weaknesses
7.7 Organogenesis
7.7.1 Organogenesis Details
7.7.2 Organogenesis Major Business
7.7.3 Organogenesis Cell Therapy Regenerative Medicine Product and Services
7.7.4 Organogenesis Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Organogenesis Recent Developments/Updates
7.7.6 Organogenesis Competitive Strengths & Weaknesses
7.8 UniQure
7.8.1 UniQure Details
7.8.2 UniQure Major Business
7.8.3 UniQure Cell Therapy Regenerative Medicine Product and Services
7.8.4 UniQure Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 UniQure Recent Developments/Updates
7.8.6 UniQure Competitive Strengths & Weaknesses
7.9 Cellular Dynamics International
7.9.1 Cellular Dynamics International Details
7.9.2 Cellular Dynamics International Major Business
7.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
7.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Cellular Dynamics International Recent Developments/Updates
7.9.6 Cellular Dynamics International Competitive Strengths & Weaknesses
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Details
7.10.2 Osiris Therapeutics Major Business
7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
7.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Osiris Therapeutics Recent Developments/Updates
7.10.6 Osiris Therapeutics Competitive Strengths & Weaknesses
7.11 Vcanbio
7.11.1 Vcanbio Details
7.11.2 Vcanbio Major Business
7.11.3 Vcanbio Cell Therapy Regenerative Medicine Product and Services
7.11.4 Vcanbio Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Vcanbio Recent Developments/Updates
7.11.6 Vcanbio Competitive Strengths & Weaknesses
7.12 Gamida Cell
7.12.1 Gamida Cell Details
7.12.2 Gamida Cell Major Business
7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Product and Services
7.12.4 Gamida Cell Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Gamida Cell Recent Developments/Updates
7.12.6 Gamida Cell Competitive Strengths & Weaknesses
7.13 Golden Meditech
7.13.1 Golden Meditech Details
7.13.2 Golden Meditech Major Business
7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Product and Services
7.13.4 Golden Meditech Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Golden Meditech Recent Developments/Updates
7.13.6 Golden Meditech Competitive Strengths & Weaknesses
7.14 Cytori
7.14.1 Cytori Details
7.14.2 Cytori Major Business
7.14.3 Cytori Cell Therapy Regenerative Medicine Product and Services
7.14.4 Cytori Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Cytori Recent Developments/Updates
7.14.6 Cytori Competitive Strengths & Weaknesses
7.15 Celgene
7.15.1 Celgene Details
7.15.2 Celgene Major Business
7.15.3 Celgene Cell Therapy Regenerative Medicine Product and Services
7.15.4 Celgene Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Celgene Recent Developments/Updates
7.15.6 Celgene Competitive Strengths & Weaknesses
7.16 Vericel Corporation
7.16.1 Vericel Corporation Details
7.16.2 Vericel Corporation Major Business
7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
7.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Vericel Corporation Recent Developments/Updates
7.16.6 Vericel Corporation Competitive Strengths & Weaknesses
7.17 Guanhao Biotech
7.17.1 Guanhao Biotech Details
7.17.2 Guanhao Biotech Major Business
7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
7.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Guanhao Biotech Recent Developments/Updates
7.17.6 Guanhao Biotech Competitive Strengths & Weaknesses
7.18 Mesoblast
7.18.1 Mesoblast Details
7.18.2 Mesoblast Major Business
7.18.3 Mesoblast Cell Therapy Regenerative Medicine Product and Services
7.18.4 Mesoblast Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Mesoblast Recent Developments/Updates
7.18.6 Mesoblast Competitive Strengths & Weaknesses
7.19 Stemcell Technologies
7.19.1 Stemcell Technologies Details
7.19.2 Stemcell Technologies Major Business
7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
7.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Stemcell Technologies Recent Developments/Updates
7.19.6 Stemcell Technologies Competitive Strengths & Weaknesses
7.20 Bellicum Pharmaceuticals
7.20.1 Bellicum Pharmaceuticals Details
7.20.2 Bellicum Pharmaceuticals Major Business
7.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
7.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Bellicum Pharmaceuticals Recent Developments/Updates
7.20.6 Bellicum Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Cell Therapy Regenerative Medicine Industry Chain
8.2 Cell Therapy Regenerative Medicine Upstream Analysis
8.2.1 Cell Therapy Regenerative Medicine Core Raw Materials
8.2.2 Main Manufacturers of Cell Therapy Regenerative Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cell Therapy Regenerative Medicine Production Mode
8.6 Cell Therapy Regenerative Medicine Procurement Model
8.7 Cell Therapy Regenerative Medicine Industry Sales Model and Sales Channels
8.7.1 Cell Therapy Regenerative Medicine Sales Model
8.7.2 Cell Therapy Regenerative Medicine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Cell Therapy Regenerative Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cell Therapy Regenerative Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cell Therapy Regenerative Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Cell Therapy Regenerative Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Cell Therapy Regenerative Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Cell Therapy Regenerative Medicine Production Market Share by Region (2018-2023)
Table 9. World Cell Therapy Regenerative Medicine Production Market Share by Region (2024-2029)
Table 10. World Cell Therapy Regenerative Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cell Therapy Regenerative Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cell Therapy Regenerative Medicine Major Market Trends
Table 13. World Cell Therapy Regenerative Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cell Therapy Regenerative Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Cell Therapy Regenerative Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cell Therapy Regenerative Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cell Therapy Regenerative Medicine Producers in 2022
Table 18. World Cell Therapy Regenerative Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cell Therapy Regenerative Medicine Producers in 2022
Table 20. World Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cell Therapy Regenerative Medicine Company Evaluation Quadrant
Table 22. World Cell Therapy Regenerative Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cell Therapy Regenerative Medicine Production Site of Key Manufacturer
Table 24. Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
Table 25. Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
Table 26. Cell Therapy Regenerative Medicine Competitive Factors
Table 27. Cell Therapy Regenerative Medicine New Entrant and Capacity Expansion Plans
Table 28. Cell Therapy Regenerative Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Cell Therapy Regenerative Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cell Therapy Regenerative Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cell Therapy Regenerative Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 37. China Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Cell Therapy Regenerative Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share (2018-2023)
Table 47. World Cell Therapy Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cell Therapy Regenerative Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Cell Therapy Regenerative Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Cell Therapy Regenerative Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cell Therapy Regenerative Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cell Therapy Regenerative Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cell Therapy Regenerative Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cell Therapy Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cell Therapy Regenerative Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Cell Therapy Regenerative Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Cell Therapy Regenerative Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cell Therapy Regenerative Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cell Therapy Regenerative Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cell Therapy Regenerative Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. DePuy Synthes Basic Information, Manufacturing Base and Competitors
Table 62. DePuy Synthes Major Business
Table 63. DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
Table 64. DePuy Synthes Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. DePuy Synthes Recent Developments/Updates
Table 66. DePuy Synthes Competitive Strengths & Weaknesses
Table 67. Medtronic Basic Information, Manufacturing Base and Competitors
Table 68. Medtronic Major Business
Table 69. Medtronic Cell Therapy Regenerative Medicine Product and Services
Table 70. Medtronic Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Medtronic Recent Developments/Updates
Table 72. Medtronic Competitive Strengths & Weaknesses
Table 73. ZimmerBiomet Basic Information, Manufacturing Base and Competitors
Table 74. ZimmerBiomet Major Business
Table 75. ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
Table 76. ZimmerBiomet Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. ZimmerBiomet Recent Developments/Updates
Table 78. ZimmerBiomet Competitive Strengths & Weaknesses
Table 79. Stryker Basic Information, Manufacturing Base and Competitors
Table 80. Stryker Major Business
Table 81. Stryker Cell Therapy Regenerative Medicine Product and Services
Table 82. Stryker Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Stryker Recent Developments/Updates
Table 84. Stryker Competitive Strengths & Weaknesses
Table 85. Acelity Basic Information, Manufacturing Base and Competitors
Table 86. Acelity Major Business
Table 87. Acelity Cell Therapy Regenerative Medicine Product and Services
Table 88. Acelity Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Acelity Recent Developments/Updates
Table 90. Acelity Competitive Strengths & Weaknesses
Table 91. MiMedx Group Basic Information, Manufacturing Base and Competitors
Table 92. MiMedx Group Major Business
Table 93. MiMedx Group Cell Therapy Regenerative Medicine Product and Services
Table 94. MiMedx Group Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. MiMedx Group Recent Developments/Updates
Table 96. MiMedx Group Competitive Strengths & Weaknesses
Table 97. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 98. Organogenesis Major Business
Table 99. Organogenesis Cell Therapy Regenerative Medicine Product and Services
Table 100. Organogenesis Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Organogenesis Recent Developments/Updates
Table 102. Organogenesis Competitive Strengths & Weaknesses
Table 103. UniQure Basic Information, Manufacturing Base and Competitors
Table 104. UniQure Major Business
Table 105. UniQure Cell Therapy Regenerative Medicine Product and Services
Table 106. UniQure Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. UniQure Recent Developments/Updates
Table 108. UniQure Competitive Strengths & Weaknesses
Table 109. Cellular Dynamics International Basic Information, Manufacturing Base and Competitors
Table 110. Cellular Dynamics International Major Business
Table 111. Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
Table 112. Cellular Dynamics International Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Cellular Dynamics International Recent Developments/Updates
Table 114. Cellular Dynamics International Competitive Strengths & Weaknesses
Table 115. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Osiris Therapeutics Major Business
Table 117. Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
Table 118. Osiris Therapeutics Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Osiris Therapeutics Recent Developments/Updates
Table 120. Osiris Therapeutics Competitive Strengths & Weaknesses
Table 121. Vcanbio Basic Information, Manufacturing Base and Competitors
Table 122. Vcanbio Major Business
Table 123. Vcanbio Cell Therapy Regenerative Medicine Product and Services
Table 124. Vcanbio Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Vcanbio Recent Developments/Updates
Table 126. Vcanbio Competitive Strengths & Weaknesses
Table 127. Gamida Cell Basic Information, Manufacturing Base and Competitors
Table 128. Gamida Cell Major Business
Table 129. Gamida Cell Cell Therapy Regenerative Medicine Product and Services
Table 130. Gamida Cell Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Gamida Cell Recent Developments/Updates
Table 132. Gamida Cell Competitive Strengths & Weaknesses
Table 133. Golden Meditech Basic Information, Manufacturing Base and Competitors
Table 134. Golden Meditech Major Business
Table 135. Golden Meditech Cell Therapy Regenerative Medicine Product and Services
Table 136. Golden Meditech Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Golden Meditech Recent Developments/Updates
Table 138. Golden Meditech Competitive Strengths & Weaknesses
Table 139. Cytori Basic Information, Manufacturing Base and Competitors
Table 140. Cytori Major Business
Table 141. Cytori Cell Therapy Regenerative Medicine Product and Services
Table 142. Cytori Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Cytori Recent Developments/Updates
Table 144. Cytori Competitive Strengths & Weaknesses
Table 145. Celgene Basic Information, Manufacturing Base and Competitors
Table 146. Celgene Major Business
Table 147. Celgene Cell Therapy Regenerative Medicine Product and Services
Table 148. Celgene Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Celgene Recent Developments/Updates
Table 150. Celgene Competitive Strengths & Weaknesses
Table 151. Vericel Corporation Basic Information, Manufacturing Base and Competitors
Table 152. Vericel Corporation Major Business
Table 153. Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
Table 154. Vericel Corporation Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Vericel Corporation Recent Developments/Updates
Table 156. Vericel Corporation Competitive Strengths & Weaknesses
Table 157. Guanhao Biotech Basic Information, Manufacturing Base and Competitors
Table 158. Guanhao Biotech Major Business
Table 159. Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
Table 160. Guanhao Biotech Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Guanhao Biotech Recent Developments/Updates
Table 162. Guanhao Biotech Competitive Strengths & Weaknesses
Table 163. Mesoblast Basic Information, Manufacturing Base and Competitors
Table 164. Mesoblast Major Business
Table 165. Mesoblast Cell Therapy Regenerative Medicine Product and Services
Table 166. Mesoblast Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Mesoblast Recent Developments/Updates
Table 168. Mesoblast Competitive Strengths & Weaknesses
Table 169. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 170. Stemcell Technologies Major Business
Table 171. Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
Table 172. Stemcell Technologies Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Stemcell Technologies Recent Developments/Updates
Table 174. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 175. Bellicum Pharmaceuticals Major Business
Table 176. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
Table 177. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Cell Therapy Regenerative Medicine Upstream (Raw Materials)
Table 179. Cell Therapy Regenerative Medicine Typical Customers
Table 180. Cell Therapy Regenerative Medicine Typical Distributors
List of Figure
Figure 1. Cell Therapy Regenerative Medicine Picture
Figure 2. World Cell Therapy Regenerative Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell Therapy Regenerative Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 5. World Cell Therapy Regenerative Medicine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cell Therapy Regenerative Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Cell Therapy Regenerative Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 10. China Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Cell Therapy Regenerative Medicine Production (2018-2029) & (K Units)
Figure 12. Cell Therapy Regenerative Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Cell Therapy Regenerative Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Cell Therapy Regenerative Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cell Therapy Regenerative Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cell Therapy Regenerative Medicine Markets in 2022
Figure 26. United States VS China: Cell Therapy Regenerative Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cell Therapy Regenerative Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell Therapy Regenerative Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cell Therapy Regenerative Medicine Production Market Share 2022
Figure 32. World Cell Therapy Regenerative Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cell Therapy Regenerative Medicine Production Value Market Share by Type in 2022
Figure 34. NK Cell Therapy
Figure 35. CAR-T Cell Therapy
Figure 36. Others
Figure 37. World Cell Therapy Regenerative Medicine Production Market Share by Type (2018-2029)
Figure 38. World Cell Therapy Regenerative Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Cell Therapy Regenerative Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Cell Therapy Regenerative Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Cell Therapy Regenerative Medicine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Medical Research Center
Figure 44. Others
Figure 45. World Cell Therapy Regenerative Medicine Production Market Share by Application (2018-2029)
Figure 46. World Cell Therapy Regenerative Medicine Production Value Market Share by Application (2018-2029)
Figure 47. World Cell Therapy Regenerative Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Cell Therapy Regenerative Medicine Industry Chain
Figure 49. Cell Therapy Regenerative Medicine Procurement Model
Figure 50. Cell Therapy Regenerative Medicine Sales Model
Figure 51. Cell Therapy Regenerative Medicine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
jiaGou

Add To Cart

gouMai

Buy Now